Santarus, Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention & treatment of gastrointestinal diseases and disorders.
| NASDAQ: SNTS |
| Current Price: 2.38 |
| Change: 0.00 |
7/19/2008 8:40:01 PM EST
Quotes delayed 20 minutes.
|
|
July 17, 2008
Santarus to Hold Second Quarter 2008 Financial Results Conference Call on August 4
July 14, 2008
Santarus Increases Revolving Line of Credit to $25 Million and Extends Maturity to July 2011
July 8, 2008
Santarus Announces Issuance Date of Additional U.S. Patent Covering Zegerid Products
|
Santarus is hiring skilled people like you. Join our team today!
